NCT03291067: A reported trial by Tanabe Pharma America, Inc.
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03291067 |
|---|---|
| Title | A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Oct. 9, 2017 |
| Completion date | Oct. 19, 2018 |
| Required reporting date | Oct. 19, 2021, midnight |
| Actual reporting date | Oct. 14, 2021 |
| Date last checked at ClinicalTrials.gov | June 3, 2026 |
| Days late | None |